200 related articles for article (PubMed ID: 30266755)
1. c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL.
Lee HY; Cha J; Kim SK; Park JH; Song KH; Kim P; Kim MY
Mol Cancer Res; 2019 Feb; 17(2):544-554. PubMed ID: 30266755
[TBL] [Abstract][Full Text] [Related]
2. Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc.
Kim DY; Kim MJ; Kim HB; Lee JW; Bae JH; Kim DW; Kang CD; Kim SH
Biochim Biophys Acta; 2011 Jul; 1812(7):796-805. PubMed ID: 21514380
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of lncRNA-CCRR contributes to brain metastasis of breast cancer by intercellular coupling via regulating connexin 43 expression.
Li D; Li L; Chen X; Zhou C; Hao B; Cao Y
J Cell Mol Med; 2021 May; 25(10):4826-4834. PubMed ID: 33793070
[TBL] [Abstract][Full Text] [Related]
4. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
[TBL] [Abstract][Full Text] [Related]
5. Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.
Lee M; Beggs SM; Gildea D; Bupp S; Lichtenberg J; Trivedi NS; ; Hu Y; Bodine DM; Crawford NP
Oncotarget; 2015 Oct; 6(31):31557-68. PubMed ID: 26384308
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
7. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
8. Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.
Bagci-Onder T; Du W; Figueiredo JL; Martinez-Quintanilla J; Shah K
Brain; 2015 Jun; 138(Pt 6):1710-21. PubMed ID: 25910782
[TBL] [Abstract][Full Text] [Related]
9. Role of connexins in metastatic breast cancer and melanoma brain colonization.
Stoletov K; Strnadel J; Zardouzian E; Momiyama M; Park FD; Kelber JA; Pizzo DP; Hoffman R; VandenBerg SR; Klemke RL
J Cell Sci; 2013 Feb; 126(Pt 4):904-13. PubMed ID: 23321642
[TBL] [Abstract][Full Text] [Related]
10. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
[TBL] [Abstract][Full Text] [Related]
11. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
Shen H; Zhao L; Feng X; Xu C; Li C; Niu Y
Oncotarget; 2016 Sep; 7(37):60407-60418. PubMed ID: 27494865
[TBL] [Abstract][Full Text] [Related]
12. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
Thapa B; Bahadur Kc R; Uludağ H
Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.
Chen Q; Boire A; Jin X; Valiente M; Er EE; Lopez-Soto A; Jacob L; Patwa R; Shah H; Xu K; Cross JR; Massagué J
Nature; 2016 May; 533(7604):493-498. PubMed ID: 27225120
[TBL] [Abstract][Full Text] [Related]
14. microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13.
Han H; Chen Y; Cheng L; Prochownik EV; Li Y
Oncotarget; 2016 Mar; 7(13):16409-19. PubMed ID: 26918941
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers.
Klotz R; Thomas A; Teng T; Han SM; Iriondo O; Li L; Restrepo-Vassalli S; Wang A; Izadian N; MacKay M; Moon BS; Liu KJ; Ganesan SK; Lee G; Kang DS; Walmsley CS; Pinto C; Press MF; Lu W; Lu J; Juric D; Bardia A; Hicks J; Salhia B; Attenello F; Smith AD; Yu M
Cancer Discov; 2020 Jan; 10(1):86-103. PubMed ID: 31601552
[TBL] [Abstract][Full Text] [Related]
16. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
[TBL] [Abstract][Full Text] [Related]
17. AS602801 treatment suppresses breast cancer metastasis to the brain by interfering with gap-junction communication by regulating Cx43 expression.
Yang Z; Yang L; Zhang J; Qian C; Zhao Y
Drug Dev Res; 2024 Feb; 85(1):e22124. PubMed ID: 37859299
[TBL] [Abstract][Full Text] [Related]
18. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect.
Luo P; Zhang C; Liao F; Chen L; Liu Z; Long L; Jiang Z; Wang Y; Wang Z; Liu Z; Miao H; Shi C
Cell Commun Signal; 2019 Apr; 17(1):36. PubMed ID: 30992017
[TBL] [Abstract][Full Text] [Related]
20. KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.
Yin L; Li Q; Mrdenovic S; Chu GC; Wu BJ; Bu H; Duan P; Kim J; You S; Lewis MS; Liang G; Wang R; Zhau HE; Chung LWK
Breast Cancer Res; 2022 Jan; 24(1):7. PubMed ID: 35078507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
